Author: Alan Woodfield
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 44
Book Description
Augmenting Reference Pricing of Pharmaceuticals with Strategic Cross-product Agreements
Author: Alan Woodfield
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 44
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 44
Book Description
Parallel Imports of Pharmaceuticals
Author: Cédric Julien Poget
Publisher: Springer Science & Business Media
ISBN: 3764385898
Category : Medical
Languages : en
Pages : 158
Book Description
Parallel trade occurs if international price differences for identical products are high and a policy of regional or international exhaustion of the respective property right has been implemented in the high price country. The work by C. Poget analyses how parallel imports of pharmaceuticals are affecting end consumer prices and drug expenditures in three Scandinavian countries, Sweden, Denmark and Norway. Based on his observations he derives proposals for policy reforms in EU member countries and Switzerland.
Publisher: Springer Science & Business Media
ISBN: 3764385898
Category : Medical
Languages : en
Pages : 158
Book Description
Parallel trade occurs if international price differences for identical products are high and a policy of regional or international exhaustion of the respective property right has been implemented in the high price country. The work by C. Poget analyses how parallel imports of pharmaceuticals are affecting end consumer prices and drug expenditures in three Scandinavian countries, Sweden, Denmark and Norway. Based on his observations he derives proposals for policy reforms in EU member countries and Switzerland.
Pharmaceutical Prices in the 21st Century
Author: Zaheer-Ud-Din Babar
Publisher: Springer
ISBN: 3319121693
Category : Business & Economics
Languages : en
Pages : 410
Book Description
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Publisher: Springer
ISBN: 3319121693
Category : Business & Economics
Languages : en
Pages : 410
Book Description
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality
Author: Mossialos, Elias
Publisher: McGraw-Hill Education (UK)
ISBN: 0335214657
Category : Education
Languages : en
Pages : 390
Book Description
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.
Publisher: McGraw-Hill Education (UK)
ISBN: 0335214657
Category : Education
Languages : en
Pages : 390
Book Description
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.
Public Health, Personal Health and Pills
Author: Kevin Dew
Publisher: Routledge
ISBN: 1315389665
Category : Medical
Languages : en
Pages : 343
Book Description
Public Health, Personal Health and Pills explores the processes and effects of the increasing governance of our lives through pharmaceuticals, looking at the moral, interactional, social and political forces that shape our use of them. It demonstrates the ways in which social relationships and identities are developed, sustained and transformed through medication use. Building on the extensive medicalisation of health literature, and the more recent concept of pharmaceuticalisation, this pioneering book is firmly based on empirical research and sociological theory. It brings together macro considerations of trends in pharmaceutical consumption, regulation and policy, micro considerations of the decision-making and the negotiation of medication use in homes and clinics, and an institutional analysis of the role of drug monitoring agencies, drug subsidising agencies, drug trial methodologies and the media. This book is a contribution to a burgeoning sociological interest in medication use, and will be of interest to a multidisciplinary audience of scholars and students of sociology, science and technology studies, pharmacy and health studies.
Publisher: Routledge
ISBN: 1315389665
Category : Medical
Languages : en
Pages : 343
Book Description
Public Health, Personal Health and Pills explores the processes and effects of the increasing governance of our lives through pharmaceuticals, looking at the moral, interactional, social and political forces that shape our use of them. It demonstrates the ways in which social relationships and identities are developed, sustained and transformed through medication use. Building on the extensive medicalisation of health literature, and the more recent concept of pharmaceuticalisation, this pioneering book is firmly based on empirical research and sociological theory. It brings together macro considerations of trends in pharmaceutical consumption, regulation and policy, micro considerations of the decision-making and the negotiation of medication use in homes and clinics, and an institutional analysis of the role of drug monitoring agencies, drug subsidising agencies, drug trial methodologies and the media. This book is a contribution to a burgeoning sociological interest in medication use, and will be of interest to a multidisciplinary audience of scholars and students of sociology, science and technology studies, pharmacy and health studies.
On Optimal Monetary Policy Rules and the Role of MCIs in the Open Economy
Author: Alfred V. Guender
Publisher:
ISBN:
Category : Foreign exchange rates
Languages : en
Pages : 36
Book Description
Publisher:
ISBN:
Category : Foreign exchange rates
Languages : en
Pages : 36
Book Description
A Finance Theory of Monetary Policy in a World Without Money
Author: Paul Dalziel
Publisher:
ISBN:
Category : Banks and banking, Central
Languages : en
Pages : 28
Book Description
Publisher:
ISBN:
Category : Banks and banking, Central
Languages : en
Pages : 28
Book Description
The Underlining Game
Author: Alan Woodfield
Publisher:
ISBN:
Category : Academic writing
Languages : en
Pages : 44
Book Description
Publisher:
ISBN:
Category : Academic writing
Languages : en
Pages : 44
Book Description
Negligence "in the Air" and New Zealand's Health and Safety in Employment Act
Author: Paul Gordon
Publisher:
ISBN:
Category : Industrial safety
Languages : en
Pages : 56
Book Description
Publisher:
ISBN:
Category : Industrial safety
Languages : en
Pages : 56
Book Description
Trade Union Objectives and Economic Growth
Author: Andreas Irmen
Publisher:
ISBN:
Category : Economic development
Languages : en
Pages : 28
Book Description
Publisher:
ISBN:
Category : Economic development
Languages : en
Pages : 28
Book Description